Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1075 | 943 | 1124 | 1157 | 1445 | 2483 |
Fund Return | 7.52% | -5.68% | 12.43% | 4.97% | 7.63% | 9.52% |
Place in category | 354 | 670 | 411 | 137 | 130 | 83 |
% in Category | 37 | 70 | 44 | 23 | 26 | 27 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust I Dist | 1.73B | 27.69 | 12.02 | 15.22 | ||
Legal General US Index Trust C Acc | 3.53B | 14.61 | 10.47 | 14.99 | ||
Legal General US Index Trust C Dist | 847.63M | 14.53 | 10.45 | 14.98 | ||
Legal General US Index Trust F Acc | 554.02K | 27.45 | 11.76 | 14.94 | ||
Legal General US Index Trust F Dist | 23.41K | 27.39 | 11.74 | 14.94 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.79B | 11.21 | 7.04 | 12.01 | ||
Wellington Global Health Care EquiG | 2B | 6.70 | 4.03 | 11.14 | ||
Global Health Care Fund W Acc GBP | 105.48M | 8.57 | 4.09 | 10.65 | ||
Adamant Medtech I GBP | 1.53B | 14.50 | 4.03 | 12.68 | ||
Pharmaceuticals Index Trust F Acc | 250.05K | 7.53 | 5.00 | 9.55 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 796.15 | +3.70% | |
UnitedHealth | US91324P1021 | 6.67 | 506.34 | +1.24% | |
J&J | US4781601046 | 4.97 | 145.27 | +0.55% | |
AbbVie | US00287Y1091 | 4.65 | 178.39 | +1.60% | |
Novo Nordisk B | DK0062498333 | 4.42 | 622.6 | +5.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review